STAT3 and congestive heart failure: This finding suggests that simvastatin combined with resistance training increases MMP and JAK/STAT3 expression levels, ameliorates mitochondrial damage, and promotes JAK/STAT3 signaling pathway activation, which may be an important mechanism for improving the condition of patients with CHF.